Enveric Biosciences Stock Analysis

Enveric Stock Analysis Notes

About 14.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.83. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enveric Biosciences recorded a loss per share of 11.05. The entity last dividend was issued on the 23rd of April 2008. The firm had 1:15 split on the 29th of January 2025. Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Enveric Biosciences, Inc. is headquartered in Naples, Florida. Enveric Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people. To learn more about Enveric Biosciences call Joseph Tucker at 239-302-1707 or check out https://www.enveric.com.

Enveric Biosciences Investment Alerts

Enveric Biosciences Upcoming and Recent Events

Enveric Largest EPS Surprises

View All Earnings Estimates

Enveric Stock Institutional Investors

Note, although Enveric Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Enveric Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.26 M.

Enveric Profitablity

Management Efficiency

Enveric Biosciences has return on total asset (ROA) of (0.837) % which means that it has lost $0.837 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7891) %, meaning that it created substantial loss on money invested by shareholders. Enveric Biosciences' management efficiency ratios could be used to measure how well Enveric Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of July 20, 2025, Return On Tangible Assets is expected to decline to -3.31. The current year's Return On Capital Employed is expected to grow to -5.74. At present, Enveric Biosciences' Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 4.2 M, whereas Total Assets are forecasted to decline to about 2.9 M.

Technical Drivers

As of the 20th of July, Enveric Biosciences shows the Downside Deviation of 4.04, coefficient of variation of 2928.63, and Mean Deviation of 2.68. Enveric Biosciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Enveric Biosciences Price Movement Analysis

Enveric Biosciences Insider Trading Activities

Enveric Biosciences Outstanding Bonds

Enveric Biosciences Predictive Daily Indicators

Enveric Biosciences Forecast Models

Enveric Biosciences' time-series forecasting models are one of many Enveric Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enveric Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Enveric Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enveric shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Enveric Biosciences. By using and applying Enveric Stock analysis, traders can create a robust methodology for identifying Enveric entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Enveric analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Enveric analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Enveric Biosciences stock analysis indicators help investors evaluate how Enveric Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Enveric Biosciences shares will generate the highest return on investment. By understating and applying Enveric Biosciences stock analysis, traders can identify Enveric Biosciences position entry and exit signals to maximize returns.

When running Enveric Biosciences' price analysis, check to measure Enveric Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enveric Biosciences is operating at the current time. Most of Enveric Biosciences' value examination focuses on studying past and present price action to predict the probability of Enveric Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enveric Biosciences' price. Additionally, you may evaluate how the addition of Enveric Biosciences to your portfolios can decrease your overall portfolio volatility.